MUMBAI, India, Oct. 26 -- Intellectual Property India has published a patent application (202611107335 A) filed by Chandigarh University on September 07, 2026, for Telmisartan Loaded Lipid Polymeric Hybrid Nanoparticles For Enhanced Bioavailability And Sustained Oral Drug Delivery.
Inventors include Shruti Sharma; Chandan Sharma; and Aditi.
The application for the patent was published on October 23, 2026, under issue no. 43/2026.
Abstract: The present invention relates to a lipid polymeric hybrid nanoparticle formulation comprising telmisartan for enhanced oral drug delivery. Telmisartan is characterized by poor aqueous solubility and limited oral bioavailability, which may result in variable absorption and reduced therapeutic effectiven...